| PERIOD ENDING | 31-Dec-02 | 31-Dec-01 | 31-Dec-00 | | Total Revenue | 9,428 | 8,818 | 7,568 | | Cost of Revenue | 1,515 | 2,524 | 2,421 | | | Gross Profit | 7,913 | 6,294 | 5,147 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 6,709 | 5,147 | 4,409 | | Non Recurring |
-
|
-
|
-
| | Others | 370 | 162 | 239 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 834 | 985 | 499 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 834 | 985 | 499 | | Interest Expense | 69 | 242 | 380 | | Income Before Tax | 765 | 743 | 119 | | Income Tax Expense | (5) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 770 | 743 | 119 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 770 | 743 | 119 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $770 | $743 | $119 |
|
1.48% Nasdaq 
Income Statement
